Follow NCPIE on Facebook

View our YouTube channel

Please consult a licensed health care professional with questions or concerns about your medication and/or condition.

Last Updated
November 20, 2015
NEWSROOM > Latest News > All
Current | 2014 News | 2013 News | Prior to 2013

- - - - -
November 19, 2015
FDA moves quickly to approve Naloxone nasal spray to treat opioid overdose
The Food and Drug Administration today approved Narcan nasal spray, the first FDA-approved nasal spray version 
of naloxone hydrochloride, a life-saving medication that can stop or reverse the effects of an opioid overdose. 
Opioids are a class of drugs that include prescription medications such as oxycodone, hydrocodone, and morphine, 
as well as the illegal drug heroin.

Drug overdose deaths, driven largely by prescription drug overdoses, are now the leading cause of injury death in 
the United States – surpassing motor vehicle crashes. In 2013, the Centers for Disease Control and Prevention 
reported the number of drug overdose deaths had steadily increased for more than a decade. When someone 
overdoses on an opioid, it can be difficult to awaken the person, and breathing may become shallow or stop – 
leading to death if there is no medical intervention. If naloxone is administered quickly, it can counter the overdose 
effects, usually within two minutes.

Narcan nasal spray does not require assembly and delivers a consistent, measured dose when used as directed. 
This prescription product can be used on adults or children and is easily administered by anyone, even those 
without medical training. The drug is sprayed into one nostril while the patient is lying on his or her back, and can 
be repeated if necessary. However, it is important to note that it is not a substitute for immediate medical care, and 
the person administering Narcan nasal spray should seek further immediate medical attention on the patient’s 

November 19, 2015
The Dr. Oz Show Organizes a National Night Of Conversation (NNOC)
NCPIE is participating in a National Night of Conversation (NNOC) as a Supporting Organization, see last page of the 
Night of Conversation Discussion Guide.  Additionally, as noted below, several NCPIE educational resources 
(including several programs developed with the Substance Abuse and Mental Health Services Administration 
(SAMHSA) are featured in the Resources Section on Dr. Oz’s  website for the National Night of Conversation.  

•Teen Influencer Program (Maximizing Your Role as a Teen 
Influencer:  What You Can Do to Help Prevent Prescription Drug Abuse). 
•Recovery Opens Doors (web platform for young adults); 
•Talking to Your Kids About Prescription Drug Abuse: Not Worth 
the Risk(brochure)
•Prescription Drugs: They Can Help But Also Hurt: Not Worth 
the Risk (brochure)
•You're in Control: Using Prescription Medicine Responsibly: 
Not Worth the Risk (for College Students) (brochure)

About the  National  Night of Conversation (NNOC)

In an effort to address the national problem of addiction, The Dr. Oz Show is organizing a National Night Of 
Conversation (NNOC) on November 19 to encourage every family in the country to sit down to dinner and talk 
to their children about drugs and to have an open and honest discourse about addiction. The NNOC is being 
conducted in partnership with Facing Addiction and Drugs Over Dinner and their many affiliated organizations.  

November 18, 2015
AMA to Press for Marijuana Warning - Use during pregnancy and breast-feeding poses potential risks
The American Medical Association agreed Monday to advocate for regulations requiring warnings be written on 
medical and recreational marijuana products and posted wherever they're sold. The decision was made based on 
studies suggesting marijuana use may be linked with low birth weight, premature birth and behavior problems in 
young children.  

Recent data  puts marijuana use during pregnancy at about 5 percent nationwide, but as high as 28 percent among 
some urban low-income women.  Critics say evidence of harm is weak, but while advocates agree that more 
research is needed, they say erring on the side of caution makes sense.

Medical marijuana is legal in 23 states and Washington, D.C. Recreational use of marijuana also is legal in 
Washington D.C., as well as in Alaska, Colorado, Oregon and Washington.

November 18, 2015
Pennsylvania Physician General signs naloxone standing order for state residents
Pennsylvania Physician General Rachel Levine, MD, has signed a standing order that will expand access to naloxone 
for all patients in the commonwealth. The order specifically provides the authorization, indications and instructions 
for using naloxone. The order is available online, and according to Dr. Levine, should only be used when an 
individual cannot obtain a prescription from his or her physician. The Pennsylvania Medical Society provides more 
information about naloxone on its website, and you also 
can view more information about naloxone, including AMA support for standing orders, on the AMA opioids Web pages.  

For information about AMA model legislation to allow for standing orders in your state, email daniel.blaney-koen@ama-assn.org

November 6, 2015
Prescription Drug Misuse Prevention in the First Year Experience, Part 1
In this 15-minute podcast, Dr. Ken Hale, Associate Director of the Higher Education Center, the Ohio State 
University, discusses prescription drug misuse prevention in the first year student experience.  This podcast is part 
1 of a two-part series. Related Resources: